United Kingdom
  • Europe
  • News
  • UK
  • World
  • Business
  • Technology
  • Science
  • Entertainment
  • Sports
  • Health

Categories

  • Artificial intelligence
  • Arts and design
  • Birmingham
  • Books
  • Boxing
  • Brexit
  • Bristol
  • Britain
  • Business
  • Celebrities
  • Computing
  • Cricket
  • Cycling
  • Economy
  • Edinburgh
  • England
  • Entertainment
  • Entrepreneurship
  • Environment
  • EU
  • F1
  • Fitness
  • Football
  • France
  • Gadgets
  • Genetics
  • Germany
  • Glasgow
  • Golf
  • Health
  • Healthcare
  • Internet
  • Jobs
  • Leeds
  • Liverpool
  • London
  • Manchester
  • Markets
  • Medication
  • Mental health
  • Mobile
  • Movies
  • Music
  • News
  • Northern Ireland
  • Nutrition
  • Personal finance
  • Physics
  • Racing
  • Royals
  • Rugby
  • Russia
  • Science
  • Scotland
  • Sheffield
  • Space
  • Spain
  • Sports
  • Technology
  • Tennis
  • TV
  • UK
  • Ukraine
  • United Kingdom
  • United States
  • Virtual reality
  • Wales
  • Wildlife
  • World
United Kingdom
  • Europe
  • News
  • UK
  • World
  • Business
  • Technology
  • Science
  • Entertainment
  • Sports
  • Health

Browsing Tag

treatment option

2 posts
MMedication
FDA Approves Expanded Indication for AJOVY® (fremanezumab-vfrm), The First Anti-CGRP Preventive Treatment for Pediatric Episodic Migraine
Read More

FDA Approves Expanded Indication for AJOVY® (fremanezumab-vfrm), The First Anti-CGRP Preventive Treatment for Pediatric Episodic Migraine

  • 6 August 2025
Teva Pharmaceutical Industries Ltd FDA approves single-dose AJOVY® (fremanezumab-vfrm) injection for the preventive treatment of episodic migraine in…
MMedication
Unicycive Provides Update on New Drug Application for Oxylanthanum Carbonate to Treat Hyperphosphatemia in Patients with Chronic Kidney Disease on Dialysis
Read More

Unicycive Provides Update on New Drug Application for Oxylanthanum Carbonate to Treat Hyperphosphatemia in Patients with Chronic Kidney Disease on Dialysis

  • 12 June 2025
Unicycive Therapeutics, Inc. – The U.S. Food and Drug Administration (FDA) identified deficiencies at a third-party manufacturing vendor…
United Kingdom
www.europesays.com